Invention Grant
- Patent Title: Formulation of human antibodies for treating TNF-alpha associated disorders
-
Application No.: US14826383Application Date: 2015-08-14
-
Publication No.: US09272042B2Publication Date: 2016-03-01
- Inventor: Hans-Juergen Krause , Lisa Baust , Michael Dickes
- Applicant: AbbVie Biotechnology Ltd
- Applicant Address: BM Hamilton
- Assignee: ABBVIE BIOTECHNOLOGY LTD
- Current Assignee: ABBVIE BIOTECHNOLOGY LTD
- Current Assignee Address: BM Hamilton
- Agency: Ropes & Gray LLP
- Agent James F. Haley, Jr.; Z. Ying Li
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; C07K16/22 ; C07K14/525 ; A61K47/26 ; A61K9/19 ; C07K16/24 ; A61K9/00 ; A61K47/10 ; A61K47/12 ; A61K47/22 ; A61K47/18 ; A61K47/02 ; A61K39/00
Abstract:
A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a pH of between about 4 and about 8, and enhanced stability.
Public/Granted literature
- US20150344563A1 FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS Public/Granted day:2015-12-03
Information query
